Trump partners with pharma to reduce drug prices.

President Trump announced new agreements with leading pharmaceutical companies to lower prescription drug prices in the US, matching prices with the lowest in developed nations. The deals involve cutting prices on medications for the Medicaid program, promising substantial savings without specific figures. Companies like Merck and Amgen will offer discounts on drugs like Januvia and Aimovig, aiming to reduce costs for US patients. Trump’s focus on price disparities between the US and other countries has led to agreements with several major drugmakers, easing concerns about tighter price controls and ensuring investments in research and manufacturing in the US.

Want More Context? 🔎